Dr David Rawson Hotelling, MD | |
477 Congress St, 5th Floor, Portland, ME 04101-3427 | |
(207) 773-6463 | |
(207) 828-4587 |
Full Name | Dr David Rawson Hotelling |
---|---|
Gender | Male |
Speciality | Internal Medicine - Endocrinology, Diabetes & Metabolism |
Location | 477 Congress St, Portland, Maine |
Accepts Medicare Assignments | Medicare enrolled and may accept medicare through third-party reassignment. May prescribe medicare part D drugs. |
Identifier | Type | State | Issuer |
---|---|---|---|
1811985963 | NPI | - | NPPES |
065366 | Other | ME | PTAN |
Taxonomy | Type | License (State) | Status |
---|---|---|---|
207RE0101X | Internal Medicine - Endocrinology, Diabetes & Metabolism | 006607 (Maine) | Primary |
Mailing Address | Practice Location Address |
---|---|
Dr David Rawson Hotelling, MD 477 Congress St, 5th Floor, Portland, ME 04101-3427 Ph: (207) 773-6463 | Dr David Rawson Hotelling, MD 477 Congress St, 5th Floor, Portland, ME 04101-3427 Ph: (207) 773-6463 |
News Archive
In this Kaiser Health News consumer column, Michelle Andrews writes: "Sarah Rose Nordgren works 25 to 30 hours a week as a waitress at an upscale restaurant in Chapel Hill, N.C."
New UC San Francisco research shows significant price differences for ten common blood tests in California hospitals, with some patients charged as little as $10 for one test while others were charged $10,169 for the identical test.
COPAN, an innovative company focused on bringing breakthrough products to Microbiology preanalytics around the world, announced that it has obtained FDA clearance for its new FecalSwab.
Nektar Therapeutics today announced positive results from a Phase 2 clinical study evaluating single-agent NKTR-102 in women with platinum-resistant/refractory ovarian cancer. A total of 68 patients were enrolled with platinum-resistant disease, half of whom were platinum refractory. All 68 patients were evaluable for the primary endpoint of objective response rate using Gynecologic Cancer InterGroup criteria, which is a combination of response by tumor imaging (RECIST) and/or ovarian cancer biomarker (CA-125) criteria.
› Verified 4 days ago
Andrew J. Hsu, M.D. Endocrinology, Diabetes & Metabolism Medicare: Medicare Enrolled Practice Location: 155 Fore River Pkwy, Portland, ME 04102 Phone: 207-535-1100 Fax: 207-879-8787 | |
David A Polisner, MD Endocrinology, Diabetes & Metabolism Medicare: Accepting Medicare Assignments Practice Location: 144 State St, Portland, ME 04101 Phone: 207-879-3000 | |
Dr. Elizabeth A Jacobs, MD Endocrinology, Diabetes & Metabolism Medicare: Accepting Medicare Assignments Practice Location: 22 Bramhall St, Portland, ME 04102 Phone: 207-662-0111 | |
Brian D Moore, M.D. Endocrinology, Diabetes & Metabolism Medicare: Accepting Medicare Assignments Practice Location: 144 State St, Portland, ME 04101 Phone: 207-879-3000 | |
Marc Stuart Hoffman, M.D. Endocrinology, Diabetes & Metabolism Medicare: Accepting Medicare Assignments Practice Location: 144 State St, Portland, ME 04101 Phone: 207-879-3265 | |
Janet D Mcculley, D.O. Endocrinology, Diabetes & Metabolism Medicare: Accepting Medicare Assignments Practice Location: 22 Bramhall St, Portland, ME 04102 Phone: 207-662-4618 | |
Saeeda Fatima, MD Endocrinology, Diabetes & Metabolism Medicare: Accepting Medicare Assignments Practice Location: 22 Bramhall St Rm 2227, Portland, ME 04102 Phone: 207-662-4618 |